Corpus ID: 34562351

[Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].

  title={[Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].},
  author={Jan Kabe{\vs} and J Sikora and Oldrich Stary and J Pisvejc and L Hanzl{\'i}cek},
  journal={Ceskoslovenska psychiatrie},
  volume={79 5},

Topics from this paper

Recent uses of piracetam in pediatric neurology
Aamir Jalal Al Mosawi Advisor in Pediatrics and Pediatric Psychiatry Children, Teaching Hospital of Baghdad Medical City Head, Iraq Headquarter of Copernicus Scientists International Panel Baghdad,Expand
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
Whether drugs, hormone-, dietary-, or herb-supplements not covered in other Cochrane reviews on TD treatments, surgical interventions, electroconvulsive therapy, and mind-body therapies were effective and safe for people with antipsychotic-induced TD is investigated. Expand
Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients
This review will discuss the evidence for a number of medications of several different classes that have been studied for the treatment of TD since the 1970s with an emphasis on placebo controlled trials when possible and suggest the use of atypical versus conventional antipsychotics whenever possible. Expand
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management
It is very disappointing to realize that the introduction of antipsychotics from the second generation has not significantly decreased the prevalence and incidence of tardive dyskinesia. Expand
Antioxidants as a Treatment and Prevention of Tardive Dyskinesia
Evidence from clinical and basic science studies that support the role of antioxidants as potential neuroprotective compounds and effective medications for the prevention and management of tardive dyskinesia is focused on. Expand
Motor Symptoms of Schizophrenia: Is Tardive Dyskinesia a Symptom or Side Effect? A Modern Treatment
This article summarizes recent relevant publications concerning TD and the most recent studies regarding treatment of this disorder with antioxidative agents. Expand
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
No strong evidence to support the everyday use of any of the agents included in this review is found and these compounds probably should only be used within the context of a well-designed evaluative study. Expand